• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外研究白藜芦醇对三阴性乳腺癌细胞上皮间质转化的逆转作用及其协同作用。

An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells.

机构信息

Department of Pharmacology, PSG College of Pharmacy, Coimbatore,India.

出版信息

J Pharm Pharmacol. 2021 Apr 27;73(6):749-757. doi: 10.1093/jpp/rgab018.

DOI:10.1093/jpp/rgab018
PMID:33769483
Abstract

BACKGROUND

Taxane based conventional chemotherapy serves as the standard treatment regimen for triple-negative breast cancer (TNBC). However, the efficacy is plateaued due to toxicities, chemoresistance and metastasis. Hence, the development of new therapies that provide long-term cover is needed. Brusatol, a natural quassinoid, has been implicated to inhibit the migration and proliferation of metastatic cells in lung and liver carcinoma, but its efficacy in TNBC has not been explored.

METHODS

The growth inhibitory activity on TNBC cells was measured using MTT assay and flow cytometry. Epithelial to mesenchymal transition (EMT) and apoptotic markers were quantified using western blotting. The caspases using Calorimetric assay.

RESULTS

Brusatol along with paclitaxel showed an enhanced growth inhibitory activity and a combined synergistic effect. In addition, brusatol was also observed to inhibit the invasion, migratory potential of TNBC cells. Mechanistically, brusatol and its combination were observed to decrease the matrix metalloproteinase (MMP) and a modest increase in the reactive oxygen species (ROS) production. Furthermore, brusatol treatment activated both intrinsic and extrinsic pathways with morphological changes of apoptosis in TNBC cells.

CONCLUSION

This is the first in vitro report demonstrating antineoplastic, anti-EMT and synergistic activity of brusatol and in combination with paclitaxel in TNBC cell. Further in-vivo studies are needed to substantiate the above findings.

摘要

背景

基于紫杉烷的常规化疗是三阴性乳腺癌(TNBC)的标准治疗方案。然而,由于毒性、化疗耐药性和转移,疗效趋于稳定。因此,需要开发提供长期覆盖的新疗法。布瑞沙托(Brusatol)是一种天然的苦木苦味素,已被证实可抑制肺癌和肝癌中转移性细胞的迁移和增殖,但它在 TNBC 中的疗效尚未得到探索。

方法

使用 MTT 法和流式细胞术测量 TNBC 细胞的生长抑制活性。使用 Western blot 定量上皮间质转化(EMT)和凋亡标志物。使用比色法测定半胱天冬酶。

结果

布瑞沙托与紫杉醇联合使用显示出增强的生长抑制活性和协同作用。此外,布瑞沙托还被观察到抑制 TNBC 细胞的侵袭和迁移能力。从机制上讲,布瑞沙托及其组合被观察到降低基质金属蛋白酶(MMP),同时适度增加活性氧(ROS)的产生。此外,布瑞沙托处理激活了内在和外在途径,并导致 TNBC 细胞发生凋亡的形态变化。

结论

这是第一项证明布瑞沙托具有抗肿瘤、抗 EMT 作用,并与紫杉醇联合具有协同作用的体外报告。需要进一步的体内研究来证实上述发现。

相似文献

1
An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells.体外研究白藜芦醇对三阴性乳腺癌细胞上皮间质转化的逆转作用及其协同作用。
J Pharm Pharmacol. 2021 Apr 27;73(6):749-757. doi: 10.1093/jpp/rgab018.
2
Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.低剂量紫杉醇联合 XAV939 通过抑制 Wnt 信号通路抑制乳腺癌转移、血管生成和生长。
Cells. 2019 Aug 14;8(8):892. doi: 10.3390/cells8080892.
3
Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.双重靶向 MDM2/MDMX 抑制剂通过激活 TAB1/TAK1/p38 MAPK 通路增加阿霉素的敏感性,并抑制三阴性乳腺癌细胞的迁移和侵袭能力。
Cancer Biol Ther. 2019;20(5):617-632. doi: 10.1080/15384047.2018.1539290. Epub 2018 Nov 21.
4
Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.通过 ROS 介导的凋亡,CoQ0 的抗 EMT 特性归因于 PI3K/AKT/NFKB/MMP-9 信号通路。
J Exp Clin Cancer Res. 2019 May 8;38(1):186. doi: 10.1186/s13046-019-1196-x.
5
1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel.1-色烯基-5-咪唑戊二烯酮对三阴性乳腺癌具有抗癌作用,并与紫杉醇具有协同作用。
Int J Mol Sci. 2020 Aug 12;21(16):5777. doi: 10.3390/ijms21165777.
6
Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.云南茜草素 C,一种从云南茜草中分离得到的天然萘二酚二聚体,通过诱导 ROS 介导的凋亡和自噬性细胞死亡来抑制三阴性乳腺癌细胞的增殖和转移。
J Ethnopharmacol. 2021 Sep 15;277:114184. doi: 10.1016/j.jep.2021.114184. Epub 2021 May 4.
7
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.甲磺酸艾日布林通过使上皮-间质转化(EMT)状态向间质-上皮转化(MET)状态逆转,抑制乳腺癌细胞的实验性转移。
Br J Cancer. 2014 Mar 18;110(6):1497-505. doi: 10.1038/bjc.2014.80. Epub 2014 Feb 25.
8
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.GSK3β 调节三阴性乳腺癌中的上皮-间充质转化和癌症干细胞特性。
Breast Cancer Res. 2019 Mar 7;21(1):37. doi: 10.1186/s13058-019-1125-0.
9
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.通过表皮生长因子受体(EGFR)和Wnt/β-连环蛋白信号调节来调整上皮-间质转化(EMT)和多药耐药(MDR)动态,以抑制三阴性乳腺癌的侵袭性。
Cell Oncol (Dordr). 2021 Apr;44(2):405-422. doi: 10.1007/s13402-020-00576-8. Epub 2021 Jan 4.
10
Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.追毒方通过 RhoA/ROCK 和 CDC42/MRCK 双信号通路抑制三阴性乳腺癌细胞的迁移和侵袭能力。
J Ethnopharmacol. 2023 Oct 28;315:116644. doi: 10.1016/j.jep.2023.116644. Epub 2023 May 16.

引用本文的文献

1
Growth Inhibition and Additive Effect to Antimalarial Drugs of Extracts on Asexual Blood-Stage .提取物对疟原虫无性血液期的生长抑制及对抗疟药物的增效作用
Pathogens. 2025 Jun 30;14(7):646. doi: 10.3390/pathogens14070646.
2
Identification of the Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay.在无细胞检测中鉴定出活性成分布鲁斯他汀为一种表皮生长因子受体酪氨酸激酶抑制剂。
ACS Omega. 2023 Jul 28;8(31):28543-28552. doi: 10.1021/acsomega.3c02931. eCollection 2023 Aug 8.
3
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway.
天然化合物,白头翁素和虎杖苷的最佳组合通过靶向 Nrf2 信号通路促进乳腺癌的抗肿瘤作用。
Int J Mol Sci. 2023 May 5;24(9):8265. doi: 10.3390/ijms24098265.
4
Major Constituents From and Their Pharmacological Actions.来自……的主要成分及其药理作用。
Front Pharmacol. 2022 Mar 18;13:853119. doi: 10.3389/fphar.2022.853119. eCollection 2022.
5
Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo.靶向抑制抗炎调节因子Nrf2可导致乳腺癌在体内外生长迟缓。
Biomedicines. 2021 Aug 30;9(9):1119. doi: 10.3390/biomedicines9091119.